DE69728608D1 - Benzimidazol-Derivate mit antihistaminischer Wirkung - Google Patents

Benzimidazol-Derivate mit antihistaminischer Wirkung

Info

Publication number
DE69728608D1
DE69728608D1 DE69728608T DE69728608T DE69728608D1 DE 69728608 D1 DE69728608 D1 DE 69728608D1 DE 69728608 T DE69728608 T DE 69728608T DE 69728608 T DE69728608 T DE 69728608T DE 69728608 D1 DE69728608 D1 DE 69728608D1
Authority
DE
Germany
Prior art keywords
benzimidazole derivatives
antihistamine activity
antihistamine
activity
benzimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69728608T
Other languages
English (en)
Other versions
DE69728608T2 (de
Inventor
Aurelio Orjales
Victor Rubio
Maravillas Bordell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faes Farma SA
Original Assignee
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA filed Critical Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority to DE122011000006C priority Critical patent/DE122011000006I1/de
Application granted granted Critical
Publication of DE69728608D1 publication Critical patent/DE69728608D1/de
Publication of DE69728608T2 publication Critical patent/DE69728608T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69728608T 1996-06-04 1997-06-03 Benzimidazol-Derivate mit antihistaminischer Wirkung Expired - Lifetime DE69728608T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE122011000006C DE122011000006I1 (de) 1996-06-04 1997-06-03 Benzimidazol-Derivate mit antihistaminischer Wirkung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (2)

Publication Number Publication Date
DE69728608D1 true DE69728608D1 (de) 2004-05-19
DE69728608T2 DE69728608T2 (de) 2005-04-21

Family

ID=8295035

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69728608T Expired - Lifetime DE69728608T2 (de) 1996-06-04 1997-06-03 Benzimidazol-Derivate mit antihistaminischer Wirkung
DE122011000006C Pending DE122011000006I1 (de) 1996-06-04 1997-06-03 Benzimidazol-Derivate mit antihistaminischer Wirkung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE122011000006C Pending DE122011000006I1 (de) 1996-06-04 1997-06-03 Benzimidazol-Derivate mit antihistaminischer Wirkung

Country Status (27)

Country Link
US (1) US5877187A (de)
EP (1) EP0818454B1 (de)
JP (1) JP4218991B2 (de)
CN (1) CN1105716C (de)
AR (1) AR008386A1 (de)
AT (1) ATE264317T1 (de)
AU (1) AU725700B2 (de)
BR (1) BR9703276A (de)
CA (1) CA2206754C (de)
CZ (1) CZ289278B6 (de)
DE (2) DE69728608T2 (de)
DK (1) DK0818454T3 (de)
ES (1) ES2124167B1 (de)
FR (1) FR11C0023I2 (de)
HR (1) HRP970307B1 (de)
HU (1) HU227598B1 (de)
IN (1) IN186319B (de)
LU (1) LU91798I2 (de)
MX (1) MXPA97004127A (de)
NO (2) NO313195B1 (de)
PL (1) PL188908B1 (de)
PT (1) PT818454E (de)
RU (1) RU2182150C2 (de)
SI (1) SI0818454T1 (de)
TR (1) TR199700464A2 (de)
TW (1) TW438794B (de)
ZA (1) ZA974893B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102470A3 (en) 1998-07-01 2002-05-28 Takeda Chemical Industries Ltd 1,3-azole derivatives as retinoid-associated receptor regulators and their use
CZ300148B6 (cs) 1998-11-27 2009-02-25 Abbott Gmbh & Co. Kg Derivát substituovaného benzimidazolu, zpusob jeho prípravy a jeho použití
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
PT1505066E (pt) * 2002-04-19 2007-03-30 Faes Farma Sa Polimorfo do ácido 4-[2-[4-[1-(2-etoxietil)-1h-benzimidazol-2-il]-1-piperidinil]etil]-alfa,alfa-dimetil-benzenoacético
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
CN101952273B (zh) * 2008-02-12 2014-11-12 柳韩洋行 2-甲基2’-苯基丙酸衍生物的制备方法和中间体化合物
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
KR102066476B1 (ko) * 2013-03-15 2020-01-15 허큘레스 엘엘씨 개선된 침적 특성을 가진 조성물 및 개선된 침적 특성을 가진 개인 관리 조성물의 제조 방법
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (de) 2014-12-29 2016-07-06 Faes Farma, S.A. Neue Benzimidazolderivate als Antihistaminmittel
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
KR102657147B1 (ko) * 2015-07-24 2024-04-12 울퀴마, 에스. 에이. 빌라스틴의 결정형 및 그의 제조 방법
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170817A1 (de) 2015-11-20 2017-05-24 Faes Farma, S.A. Cokristalle von benzimidazolverbindungen
EP3170816A1 (de) 2015-11-20 2017-05-24 Faes Farma, S.A. Übersättigte zusammensetzungen von benzimidazolverbindungen
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
EP3452462A4 (de) * 2016-05-05 2019-10-23 MSN Laboratories Private Limited, R&D Center Feststoffformen von 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methyl-propansäure und verfahren zur herstellung davon
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
ES2813561T3 (es) 2017-09-07 2021-03-24 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende bilastina
CA3079303A1 (en) 2017-10-16 2019-04-25 Faes Farma, S.A. Aqueous compositions comprising bilastine and mometasone
EP3641735B1 (de) 2017-12-18 2021-02-24 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmazeutische tablettenzusammensetzung mit bilastinform 3 und wasserlöslichem füllstoff
ES2835287T3 (es) 2017-12-18 2021-06-22 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica de comprimido que comprende la forma polimórfica 3 de bilastina y aluminometasilicato de magnesio
PL3740191T3 (pl) 2018-01-18 2021-11-29 Faes Farma, S.A. Kompozycje oftalmiczne zawierające bilastynę, beta-cyklodektrynę i co najmniej jeden środek żelatujący
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (de) 2019-04-16 2020-10-21 Faes Farma, S.A. Stabile und konservierte pharmazeutische zusammensetzungen von bilastin
CR20230109A (es) 2020-07-30 2023-05-11 Faes Farma Sa Sistema de liberación de fármacos descongestivos y bilastina
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
US20230414597A1 (en) 2020-11-18 2023-12-28 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound
EP4267109A1 (de) 2020-12-23 2023-11-01 Noucor Health S.A. Nichtmikronisierte bilastinzusammensetzung
AU2023221541A1 (en) 2022-02-17 2024-08-08 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
DK0815860T3 (da) * 1992-08-03 2006-08-14 Sepracor Inc Terfenadincarboxylat og behandlingen af allergiske lidelser
CN1275916C (zh) * 1993-06-25 2006-09-20 阿温蒂斯公司 用于制备抗组胺哌啶衍生物的新中间体

Also Published As

Publication number Publication date
ES2124167B1 (es) 1999-09-16
HRP970307B1 (en) 2002-02-28
PL320358A1 (en) 1997-12-08
JP4218991B2 (ja) 2009-02-04
US5877187A (en) 1999-03-02
HU227598B1 (en) 2011-09-28
CZ289278B6 (cs) 2001-12-12
ATE264317T1 (de) 2004-04-15
DK0818454T3 (da) 2004-07-12
MXPA97004127A (es) 2005-07-25
PT818454E (pt) 2004-08-31
PL188908B1 (pl) 2005-05-31
CN1176964A (zh) 1998-03-25
AU725700B2 (en) 2000-10-19
CA2206754C (en) 2007-01-23
NO972525D0 (no) 1997-06-03
AU2467297A (en) 1997-12-11
CN1105716C (zh) 2003-04-16
ZA974893B (en) 1997-12-30
IN186319B (de) 2001-08-04
TR199700464A3 (tr) 1997-12-21
CZ172397A3 (en) 1997-12-17
TR199700464A2 (xx) 1997-12-21
NO2011008I1 (no) 2011-06-06
FR11C0023I2 (fr) 2012-03-16
LU91798I2 (fr) 2011-05-23
TW438794B (en) 2001-06-07
DE122011000006I1 (de) 2011-06-16
NO972525L (no) 1997-12-05
HUP9700997A1 (hu) 1999-09-28
NO2011008I2 (no) 2012-05-14
EP0818454A1 (de) 1998-01-14
HRP970307A2 (en) 1998-04-30
JPH1059961A (ja) 1998-03-03
EP0818454B1 (de) 2004-04-14
DE69728608T2 (de) 2005-04-21
ES2124167A1 (es) 1999-01-16
NO313195B1 (no) 2002-08-26
AR008386A1 (es) 2000-01-19
FR11C0023I1 (de) 2011-08-19
SI0818454T1 (en) 2004-08-31
CA2206754A1 (en) 1997-12-04
RU2182150C2 (ru) 2002-05-10
HU9700997D0 (en) 1997-07-28
BR9703276A (pt) 2004-08-17

Similar Documents

Publication Publication Date Title
DE69728608D1 (de) Benzimidazol-Derivate mit antihistaminischer Wirkung
DE122005000003I1 (de) Heterocyclische Azahexanderivate mit Antiviraler wirkung.
ATE246700T1 (de) Benzimidazolderivate
DE69525418D1 (de) Benzimidazol-derivate
NO994791D0 (no) Nikotinamid-derivater
ATE323682T1 (de) Aryl-pyrimidin-derivate
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
NO983356L (no) Nye 19-nor-pregnenderivater
NO981946D0 (no) Imidazoquinazolin-derivater
NO932146D0 (no) Benzimidazolderivater
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
DE69933135D1 (de) Benzimidazolderivate mit vitronectinrezeptor-antagonistischer wirkung
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
NO20005271L (no) Optisk aktive tetrahydrobenzindol-derivater
FIU970544U0 (fi) Laakeripesä
DE69721846D1 (de) Hosenträger
NO992302D0 (no) Piperidin-derivater
DE69710921D1 (de) Heterocyclische substituierte pyrrolidinamid-derivate
DK0886645T3 (da) Nye 19-nor-pregnen-derivater
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate